Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jason Lunn
Observed name:
J. Lunn
Institution:
Institute of Cancer Research
Observed institution:
Institute of Cancer Research
ORCID:
0000-0001-9214-6645
Observed ORCID:
0000-0001-9214-6645
OpenAlex ID:
A5025403444
A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis
2023
·
Amani Arthur
, Matthew R Orton
, et al.
·
The Lancet Oncology
·
74
PDF
Splenic volume as a predictor of treatment response in patients with non-small cell lung cancer receiving immunotherapy
2022
·
Francesca Castagnoli
, Simon Doran
, et al.
·
PLoS ONE
·
23
PDF
Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
2022
·
Sumeet Hindocha
, Thomas G. Charlton
, et al.
·
npj Precision Oncology
·
20
PDF
Author Correction: Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
2022
·
Sumeet Hindocha
, Thomas G. Charlton
, et al.
·
npj Precision Oncology
·
1
PDF
MO-0384 A CT-radiomics model to predict recurrence post curative-intent radiotherapy for stage I-III NSCLC
2022
·
S. Hindocha
, T. Charlton
, et al.
·
Radiotherapy and Oncology
·
1
162P A CT radiomics model to predict overall survival following curative-intent radiotherapy for stage I-III non-small cell lung cancer
2022
·
S. Hindocha
, T.G. Charlton
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
6
Citation count:
119
H-index:
3
I10-index:
3
Year
Topic
Type